What's Happening?
Meatly, a company specializing in cultivated meat for pet food, has announced plans to build a new production facility in the UK after securing £10.4 million ($14.16 million) in Series A funding. The facility, which will feature a 20,000-litre bioreactor,
is set to be the largest of its kind in Europe. Meatly aims to use this site to produce cultivated chicken continuously. Founded in 2022, the company has already launched the world's first cultivated pet food and received regulatory clearance in the UK. The funding round was supported by investors including Oyster Bay Venture Capital and Clean Growth Fund.
Why It's Important?
The expansion of Meatly's production capabilities represents a significant step forward in the cultivated meat industry, particularly in the pet food sector. This development highlights the growing interest and investment in sustainable food production methods that reduce environmental impact. By producing meat in a lab setting, Meatly aims to offer a cost-competitive alternative to traditional meat, potentially transforming the pet food market. The move also underscores the increasing acceptance and regulatory support for lab-grown meat products, which could pave the way for broader consumer adoption and market growth.
What's Next?
Meatly plans to begin fit-out work on the new facility immediately, with product releases scheduled for the following year. The company will focus on scaling its operations and reducing production costs to make cultivated meat more accessible. As the facility becomes operational, Meatly will likely seek further regulatory approvals and expand its product range. The success of this venture could influence other companies in the food industry to invest in similar technologies, potentially leading to a shift in how meat is produced and consumed globally.
